Home/Filings/4/0001209191-20-046470
4//SEC Filing

WHIMS JAMES L 4

Accession 0001209191-20-046470

CIK 0000817720other

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 7:17 PM ET

Size

14.9 KB

Accession

0001209191-20-046470

Insider Transaction Report

Form 4
Period: 2020-08-10
Transactions
  • Exercise/Conversion

    Common Stock

    2020-08-10$46.50/sh+4,500$209,25031,262 total
  • Sale

    Common Stock

    2020-08-10$85.42/sh3,106$265,31328,156 total
  • Sale

    Common Stock

    2020-08-10$86.16/sh1,031$88,83227,125 total
  • Sale

    Common Stock

    2020-08-10$87.88/sh250$21,97026,875 total
  • Exercise/Conversion

    Director Stock Option (Right to Buy)

    2020-08-104,5000 total
    Exercise: $46.50Exp: 2020-10-28Common Stock (4,500 underlying)
  • Sale

    Common Stock

    2020-08-10$88.99/sh113$10,05626,762 total
Footnotes (5)
  • [F1]The shares were sold pursuant to a 10b5-1 Trading Plan dated June 2, 2020.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.78, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.82 to $86.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.65 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2013 date of grant, until fully vested on October 28, 2014.

Issuer

SYNAPTICS Inc

CIK 0000817720

Entity typeother

Related Parties

1
  • filerCIK 0001216815

Filing Metadata

Form type
4
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 7:17 PM ET
Size
14.9 KB